Greg is a distinguished Clinical Biostatistician with an extensive track record spanning over three decades across prominent sectors, including Medical Device, Pharmaceutical, Biotechnology, and Contract Research Organizations (CROs). His tenure in these industries has been marked by noteworthy achievements, where his expertise has made a substantial impact.In the realm of regulatory submissions, Greg has been a driving force behind the success of Premarket Approvals (PMAs), New Drug Applications (NDAs), Initial Public Offerings (IPOs), and pivotal Business Partnerships. His contributions have played an instrumental role in obtaining regulatory approvals, securing substantial investments, and forging vital industry collaborations.Furthermore, Greg has demonstrated remarkable leadership by overseeing Biostatistics and Clinical Data Management groups, instilling efficiency and precision in these critical functions. His initiatives have transformed several organizations by establishing and cultivating in-house capabilities for biostatistics, SAS programming, data management encompassing Electronic Data Capture (EDC), Interactive Data Capture (IDC), and Dynamic Data Capture (DDC), as well as medical writing.One of Greg's hallmark skills is his exceptional talent in talent management. He excels in recruiting and retaining top-tier staff, fostering an environment where excellence thrives. His ability to attract, develop, and nurture top talents is a testament to his capacity to build high-performing teams that drive results.In summary, Greg's outstanding career showcases not only a wealth of experience but also an unswerving commitment to innovation and excellence. His leadership, expertise, and vision have left an indelible mark on the biomedical and pharmaceutical industries.Specialties: Biostatistics, Clinical Trials, Digital Health
Listed skills include Clinical Trials, Clinical Data Management, Cro, Clinical Development, and 40 others.